This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

John D. Adams, FACD
Private Bag Wellington Hospital Riddiford Street Newtown, Wellington New Zealand

Arch Dermatol. 1983;119(10):793.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

I read with interest the report by Vanderveen et al in the September ARCHIVES (1982;118:660-662) concerning the use of methotrexate and etretinate as concurrent therapies in severe psoriasis. I would like to add an almost identical case to the record. The possibility of drug interactions makes it important to document safe and successful treatment regimens.

I saw a 46-year-old man who had suffered from severe erythrodermic and exfoliative psoriasis for seven years. In the previous two years the patient had spent half of his life as a hospital inpatient for treatment of his disease. The basic therapy had been coal tar ointment applied topically and weekly intravenous (IV) methotrexate. During 1982 episodes of pustulation began on the limbs, associated with fever and leukocytosis. In September he was extremely ill with staphylococcal bacteremia and it was decided to add etretinate to his therapy. Having had no previous experience . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?